Zentiva Group, a.s.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zentiva Group, a.s. - overview
Established
1488
Location
Prague, -, Czech Republic
Primary Industry
Pharmaceuticals
About
Founded in 1488 and based in Prague, Czech Republic, Zentiva Group, a. s. , also known as Zentiva, operates as a developer and manufacturer of drugs and medicine for metabolic disorders, cardiovascular, central nervous system, urology, and respiratory diseases. In 1488, Zentiva started as a small pharmacy business named Black Eagle Pharmacy in Prague.
In 1946, the company was nationalized by the Czech government. In 1993, the company changed its name to Zentiva Group, a. s.. In September 2025, GTCR acquired Zentiva Group, a.
s. from Advent International for EUR 4. 1 billion. Zentiva's main products and services include pharmaceutical drugs R&D and manufacturing for client companies.
The company produces and markets generic and OTC medicines. Zentiva's products are used for treating therapeutic areas such as cardiovascular, anti-inflammatory, urology, gastrointestinal, central nervous system, etc.
Current Investors
Advent International
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.zentiva.cz
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Zentiva Group, a.s. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Announced | Zentiva Group, a.s. | - | ||||||||
| Private Debt | Completed | Zentiva Group, a.s. | - | ||||||||
| Add-on | Completed | Alvogen's Central and Eastern European Division | - | ||||||||
| Add-on | Completed | Creo Pharma Limited | - | ||||||||
| Buyout | Completed | Zentiva Group, a.s. | - |
Displaying 1 - 5 of 9
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.